Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties - Non-oncology Endocrinology/Neuroendocrine

Diagnostic Utility of Al18F-NOTA-LM3 PET/CT in Tumor-Induced Osteomalacia: A Preliminary Prospective Study

Yuwei Zhang, Meixi LIU, Peipei Wang and Hongli Jing
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241894;
Yuwei Zhang
1Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meixi LIU
1Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peipei Wang
2Peking Union Medical College Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongli Jing
3Peking Uion Medical College Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 65 no. supplement 2 241894

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online June 9, 2024.

Copyright & Usage 
© 2024

Author Information

  1. Yuwei Zhang,
  2. Meixi LIU1,
  3. Peipei Wang2 and
  4. Hongli Jing3
  1. 1Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China
  2. 2Peking Union Medical College Hospital
  3. 3Peking Uion Medical College Hospital

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: June 2024 to April 2025

AbstractFullPdf
Jun 20242400
Jul 202413900
Aug 202410400
Sep 20241400
Oct 20244500
Nov 20243600
Dec 20243500
Jan 20251800
Feb 20251400
Mar 20251700
Apr 20253100
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic Utility of Al18F-NOTA-LM3 PET/CT in Tumor-Induced Osteomalacia: A Preliminary Prospective Study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Diagnostic Utility of Al18F-NOTA-LM3 PET/CT in Tumor-Induced Osteomalacia: A Preliminary Prospective Study
Yuwei Zhang, Meixi LIU, Peipei Wang, Hongli Jing
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241894;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Diagnostic Utility of Al18F-NOTA-LM3 PET/CT in Tumor-Induced Osteomalacia: A Preliminary Prospective Study
Yuwei Zhang, Meixi LIU, Peipei Wang, Hongli Jing
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241894;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Usefulness of 4D SPECT/CT 99mTc-sestamibi imaging in patients with primary hyperparathyroidism
  • The Value of 68Ga-DOTATATE PET/CT in Assessing the Inflammatory Activity of Extraocular Muscles in Thyroid Associated Orbitopathy
  • 18F-ALF-NOTA-pentixather PET/CT targeting CXCR4 in patients with suspected primary hyperaldosteronism
Show more General Clinical Specialties - Non-oncology Endocrinology/Neuroendocrine

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire